CHM Teabag Decrease Stroke Risk Among Hong Kong Elderly

• Status: Recruiting
• Trial end date: 2023-10-31
• Target enrollment: 0
• Participant gender: All

Summary

This stepped wedge cluster randomized controlled trial aims to examine the efficacy and safety of CHM teabag in decreasing stroke risk by machine-learning-based retinal image analysis in elderly population.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hong Kong Baptist University

Criteria

Inclusion Criteria:

• Age between 54-84y.

• With phlegm dampness constitution and blood stasis constitution on the TCM constitution test table.

• Stable vital signs without previous history of stroke.

• Sufficient sensorimotor and language competency for completing assessments.

Exclusion Criteria:

• Allergic history to Chinese herbal drugs or a known allergy to the ingredients of the teabag.

• Taking any anticoagulants, such as warfarin.

• With unconsciousness, aphasia, and cognitive dysfunction.

• With a past history of brain diseases (e.g., mental illness, consciousness disorder due to head trauma, previous brain surgery, or spastic disease).

• With severe heart, liver, or kidney disease or bleeding disorders.

• With other serious diseases.

• Cataracts or other eye diseases that affected retinal image taking.

• Distressed with a flashlight or have experience with photosensitive seizures.

• Pregnancy or lactation female.

• Any physical examination findings, or history of any illness, or concomitant medications that, in the opinion of the study investigator, might not be suitable to participate in the study.